Bratschi provides legal counsel to The Viking Cruises Group in the issuance of USD 720 million Unsecured Notes. The transaction was facilitated by Joint Book-Running Managers including Wells Fargo Securities, BofA Securities, HSBC, Morgan Stanley, UBS
Tags :sx1
Dentons has appointed Victoria White (pictured) as Global Compliance Officer, reporting to John Koski, Global Chief Legal Officer. White, a dual US/UK qualified and highly experienced General Counsel and board member, brings a wealth
Arbitration
Events
Exploring Fairness in International Arbitration: Highlights from the Italian Arbitration
The international arbitration community recently converged in Milan for the second edition of the Italian Arbitration Day (IAD), organized by the Milan Arbitration Chamber (CAM) and the Italian Arbitration Association (AIA). The event brought together
Disruptive Capital Acquisition Company Limited, a SPAC listed on the Euronext Amsterdam Exchange, has transformed into Global InterConnection Group, following its merger with Global InterConnection Group. The transaction, valued at over CHF 200 million, establishes
International law firm Charles Russell Speechlys has announced its expansion into Southeast Asia with the official opening of its Singapore office. The new office will be headed by partner Jeffrey Lee (pictured), who is currently
DePoly‘s goal is to create a cleaner world for future generations by converting PET waste to premium quality raw materials for reuse. DePoly has developed a unique and innovative process to recycle all PET
GEODIS INTERNATIONAL, a renowned firm focus on transport and logistics, expanded its global footprint with the acquisition of a 100% interest in the Swiss freight forwarder, ITS – International Transport & Shipping. The deal, closed on 31 May 2023,
The Farner group, a portfolio company of Waterland Private Equity, partnered with GFD Gesellschaft für Finanzkommunikation to expand its agency alliance “Team Farner“. Founded in Frankfurt in 1995, GFD is a financial communications consultancy specializing
UBS, acting through its London branch, successfully completed its issuance of (i) CHF 310 million aggregate principal amount of 2.385 per cent. Notes due 2025, and (ii) CHF 150 million aggregate principal amount of 2.550 per cent. Notes due 2029, in
Ironwood Pharmaceuticals (Nasdaq: IRWD), a healthcare company specializing in GI treatments, and VectivBio Holding (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe rare gastrointestinal conditions, have reached an agreement where&
